Asan Medical Center | Clinical Trial Center
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Researchers want to learn if sacituzumab tirumotecan (MK-2870) alone or with chemotherapy can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are either advanced (the cancer has spread to other parts of the body), or unresectable (the cancer cannot be removed with surgery). The goals of this study are to learn:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The main inclusion criteria include but are not limited to the following:
Has one of the following cancers:
Has received prior therapy for the cancer
Has recovered from any side effects due to previous cancer treatment
Exclusion criteria
The main exclusion criteria include but are not limited to the following:
Primary purpose
Allocation
Interventional model
Masking
130 participants in 2 patient groups
Loading...
Central trial contact
Toll Free Number
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal